The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of docetaxel plus carboplatin versus docetaxel in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial.
 
Esther W. Bouman-Wammes
Research Funding - Sanofi (Inst)
 
Linda de Munck
No Relationships to Disclose
 
H Pieter van den Berg
No Relationships to Disclose
 
Aart Beeker
No Relationships to Disclose
 
Carolien H. Smorenburg
Travel, Accommodations, Expenses - Roche
 
Henk M.W. Verheul
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Merck (Inst); Roche (Inst)
Research Funding - Immunovo (Inst); Roche (Inst); Vitromics (Inst)
 
Winald R. Gerritsen
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; CureVac; Janssen-Cilag; Merck Sharp & Dohme; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
 
Alfonsus Johannes Maria van den Eertwegh
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Research Funding - Roche; Sanofi
Travel, Accommodations, Expenses - MSD Oncology; Pfizer; Roche